Annexon Q1 net loss $44.1M ($0.23/sh); cash $225M; GA Ph3 data Q4 2026

Annexon, Inc.

2026-Q1 EPS reported -$0.23

Net loss $44.1M (-$0.23/sh) vs $54.4M (-$0.37/sh) Q1 2025; R&D $35.8M, G&A $10.3M.
Cash $225M as of March 31, 2026; expected runway into H2 2027.
Topline Phase 3 ARCHER II data for vonaprument in GA expected Q4 2026.
Tanruprubart MAA under EMA review; BLA submission with FORWARD data planned 2026.
ANX1502 proof-of-concept data in CAD anticipated in 2026.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Annexon, Inc. reported first quarter ended March 31, 2026 results: net income $44.1 million or $0.23 per share, EPS $0.23 per share.

Period: first quarter ended March 31, 2026
Net income: $44.1 million or $0.23 per share
EPS: $0.23 per share
Result: reported results

Exact text from the filing

March 31, 2025. The change in G&A expenses reflects ongoing corporate consulting and professional services costs. • Net loss: Net loss attributable to common stockholders was $44.1 million or $0.23 per share for the quarter ended March 31, 2026, compared to $54

View on SEC.gov

Browse all earnings releases →

Annexon, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-211863

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.